HCW Biologics Investor
Clinical-stage biopharmaceutical companyВідповідно до джерел: 2HCW Biologics (NASDAQ: HCWB) is a clinical-stage biopharmaceutical company developing proprietary immunotherapies to treat diseases promoted by chronic inflammation, especially age-related and senescence-associated for Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United Biologics Inc. (
Number Of Exists:
Series B
Industry:
Biotechnology, Heath and Wellness Technology
Headquarters:
Hollywood
Technology:
Biotechnology, Heath and Wellness Technology
Founded Date:
2018.0